News

Fierce Pharma22h
Summit stock crashes as Akeso shares bispecific's first overall survival data in Keytruda head-to-head trial
Akeso has shared for the first time overall survival data from a high-profile Keytruda head-to-head trial for its PD-1xVEGF ...
Fierce Pharma1d
With industry's onshoring tide rolling on, Amgen blueprints $900M expansion at Ohio biomanufacturing plant
After unveiling a new drug substance facility in North Carolina in December, Amgen is doubling down on expanding its U.S. | ...